Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 358

Results For "drug"

4440 News Found

Takeda announces approval of Nuvaxovid Covid-19 vaccine in Japan
Drug Approval | April 19, 2022

Takeda announces approval of Nuvaxovid Covid-19 vaccine in Japan

Approval for primary and booster immunization is based on efficacy and safety data from Japan and international clinical studies


Akron Bio completes plasmid DNA manufacturing facility
News | April 19, 2022

Akron Bio completes plasmid DNA manufacturing facility

The facility will support clinical development by securing supply that will address the critical demand in the gene therapy and vaccine markets


Zydus Lifesciences receives final approval from USFDA for Cyanocobalamin Injection
Drug Approval | April 18, 2022

Zydus Lifesciences receives final approval from USFDA for Cyanocobalamin Injection

The drug will be manufactured at the group's injectables manufacturing facility at Jarod, Gujarat


SonoScape receives USFDA 510(k) clearance for HD-550 Endoscopy system
Drug Approval | April 18, 2022

SonoScape receives USFDA 510(k) clearance for HD-550 Endoscopy system

The HD-550 endoscopy system has been available outside of the USA since 2019


Amneal achieves second U.S. biosimilars approval with Alymsys
Drug Approval | April 18, 2022

Amneal achieves second U.S. biosimilars approval with Alymsys

Marks the second of three biosimilars Amneal expects to receive U.S. approval for in 2022


Geocann and Averix Bio to partner on API phytocannabinoid ingredients
News | April 18, 2022

Geocann and Averix Bio to partner on API phytocannabinoid ingredients

This partnership allows both companies to become first movers to bridge an inevitable gap with the largest organizations in the pharmaceutical, nutraceutical, cosmetic, and veterinary sectors


Lupin receives tentative approval from USFDA for Tenofovir Alafenamide Tablets
Drug Approval | April 18, 2022

Lupin receives tentative approval from USFDA for Tenofovir Alafenamide Tablets

This product will be manufactured at Lupin’s Nagpur facility in India


Jubilant Ingrevia augments its CDMO presence with Rs 270 crore contract
Biotech | April 17, 2022

Jubilant Ingrevia augments its CDMO presence with Rs 270 crore contract

Through the contract, the company will supply two key GMP intermediates for one of the 'patented drugs' of the innovator pharmaceutical customer


PLI scheme to achieve Aatma Nirbhar Bharat: Dr Manshukh Mandaviya
News | April 17, 2022

PLI scheme to achieve Aatma Nirbhar Bharat: Dr Manshukh Mandaviya

The minister exhorted the pharmaceutical sector to prepare a plan for the next 25 years


Ashland expands distribution deal with Univar for pharma ingredients
News | April 15, 2022

Ashland expands distribution deal with Univar for pharma ingredients

Under the agreement, Univar Solutions customers in Brazil and Mexico will have access to Ashland's binders and disintegrants for solid dosage forms, matrix formers for modulated release drugs and coatings for regular and modulated release solid dosage forms